In clinical trials, complexity is inevitable — but how organizations respond to challenges can define success. This conversation with Steve Geffon explores how proactive problem-solving and strong ...

Inclusion is bigger than policy or workplace acronyms. It’s a way of living and fostering greater outcomes, writes Novo ...

Pharma and biotech companies can use AI to effectively and efficiently communicate with providers and patients, writes Jenna ...

This article examines FDA guidance on payment and reimbursement for clinical trial participants, with commentary highlighting key considerations for ethical and effective compensation. It clarifies ...

Having been in the industry for more than 25 years, Patrick Guertin knows that cells can be temperamental and don’t like to be rushed, but in today’s biopharma industry speed to market is key. Guertin ...

In the July issue of Life Science Leader, Cliff Mintz wrote a global update on follow-on biologics in unregulated markets, the European Union, and the United States. With intense public debate around ...

Eurofins PSS Insourcing Solutions is a strategic, compliant, and stable alternative to traditional staffing models, enabling biotech, pharmaceutical, and CDMO organizations to meet operational demands ...

On this week's episode, Cyril Konto, M.D., president, executive director, and CEO at Ichnos Glenmark Innovation (IGI) talks about the promise of multi-specific antibodies, funding the company during ...

Artificial intelligence is reshaping drug discovery, but its integration raises critical questions: How do we balance AI-driven insights with data integrity, human expertise, and ethical ...

Novartis is making a major investment in North Carolina’s Research Triangle, committing $771 million across three projects that will strengthen U.S. pharmaceutical manufacturing. The expansion ...

Advancements in science and technology, combined with unmet patient needs, are driving accelerated timelines and creative pathways for oncology drug development. While public desire for novel and ...

The term Big Data is on everyone’s lips, from retailers to healthcare providers. But what actually is it, and how can it help biopharma R&D? There are many definitions of Big Data, but perhaps the ...